ondansetron has been researched along with Absence Seizure in 11 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To document ondansetron-induced dystonia, hypoglycemia, and seizures in a child." | 7.77 | Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. ( Manchanda, S; Mittal, S; Patel, A; Puliyel, JM, 2011) |
| "A generalized tonic-clonic seizure occurred in each patient--12, 15, and 22 min after injection." | 5.35 | Ondansetron and seizures. ( Acharya, JN; Rai, A; Selhorst, JB; Singh, NN, 2009) |
| "To document ondansetron-induced dystonia, hypoglycemia, and seizures in a child." | 3.77 | Ondansetron-induced dystonia, hypoglycemia, and seizures in a child. ( Manchanda, S; Mittal, S; Patel, A; Puliyel, JM, 2011) |
| "PTZ-kindled mice showed high seizure activity, hippocampal neuronal loss, and expression of growth-associated phosphoprotein (GAP-43) compared with saline-treated mice." | 1.42 | Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors. ( Alhaj, MW; Moustafa, YM; Zaitone, SA, 2015) |
| "Firstly, seizure latency was significantly prolonged by a 5-HT3 receptor agonist SR 57227 in a dose-dependent manner." | 1.40 | The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice. ( Cui, R; Dong, X; Li, B; Liu, C; Lv, J; Shao, D; Song, Y; Sun, Z; Wang, L; Wang, P; Zhang, X; Zhao, J; Zhou, Y, 2014) |
| "Ondansetron is a highly selective 5-hydroxytryptamine 3 (5-HT(3)) receptor antagonist used as antiemetic agent for chemotherapy-, and radiotherapy-induced nausea and vomiting." | 1.38 | Evaluation of anticonvulsant and nootropic effect of ondansetron in mice. ( Agarwal, NB; Jain, S; Mediratta, PK; Sharma, KK, 2012) |
| "A generalized tonic-clonic seizure occurred in each patient--12, 15, and 22 min after injection." | 1.35 | Ondansetron and seizures. ( Acharya, JN; Rai, A; Selhorst, JB; Singh, NN, 2009) |
| "The effects of seizures were observed to a much larger extent in malformed than in normal brain tissue." | 1.33 | Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development. ( Bassanini, S; Battaglia, G; Caccia, S; Chimenti, S; Gagliardi, B; Guiso, G; Marchi, N; Noé, F; Ravizza, T; Rizzi, M; Vezzani, A, 2006) |
| " Further detailed pharmacokinetic studies of irinotecan in patients receiving concomitant therapy with enzyme-inducing anticonvulsants are required so that rational dosing recommendations can be provided for this patient population." | 1.31 | Influence of phenytoin on the disposition of irinotecan: a case report. ( Berg, S; Bernstein, M; Blaney, SM; Cherrick, I; Kuttesch, N; Murry, DJ; Salama, V, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B | 1 |
| Wang, L | 1 |
| Sun, Z | 1 |
| Zhou, Y | 1 |
| Shao, D | 1 |
| Zhao, J | 1 |
| Song, Y | 1 |
| Lv, J | 1 |
| Dong, X | 1 |
| Liu, C | 1 |
| Wang, P | 1 |
| Zhang, X | 1 |
| Cui, R | 1 |
| Alhaj, MW | 1 |
| Zaitone, SA | 1 |
| Moustafa, YM | 1 |
| Mishra, A | 1 |
| Goel, RK | 1 |
| George, M | 1 |
| Al-Duaij, N | 1 |
| O'Donnell, KA | 1 |
| Shannon, MW | 1 |
| Singh, NN | 1 |
| Rai, A | 1 |
| Selhorst, JB | 1 |
| Acharya, JN | 1 |
| Patel, A | 1 |
| Mittal, S | 1 |
| Manchanda, S | 1 |
| Puliyel, JM | 1 |
| Jain, S | 1 |
| Agarwal, NB | 1 |
| Mediratta, PK | 1 |
| Sharma, KK | 1 |
| Marchi, N | 1 |
| Guiso, G | 1 |
| Caccia, S | 1 |
| Rizzi, M | 1 |
| Gagliardi, B | 1 |
| Noé, F | 1 |
| Ravizza, T | 1 |
| Bassanini, S | 1 |
| Chimenti, S | 1 |
| Battaglia, G | 1 |
| Vezzani, A | 1 |
| Sargent, AI | 1 |
| Deppe, SA | 1 |
| Chan, FA | 1 |
| Sharma, A | 1 |
| Raina, V | 1 |
| Murry, DJ | 1 |
| Cherrick, I | 1 |
| Salama, V | 1 |
| Berg, S | 1 |
| Bernstein, M | 1 |
| Kuttesch, N | 1 |
| Blaney, SM | 1 |
11 other studies available for ondansetron and Absence Seizure
| Article | Year |
|---|---|
The anticonvulsant effects of SR 57227 on pentylenetetrazole-induced seizure in mice.
Topics: Animals; Anticonvulsants; gamma-Aminobutyric Acid; Hippocampus; Male; Mice, Inbred ICR; Ondansetron; | 2014 |
Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors.
Topics: Animals; Anticonvulsants; Cell Death; Disease Models, Animal; Fluvoxamine; GAP-43 Protein; Hippocamp | 2015 |
Chronic 5-HT
Topics: Animals; Anticonvulsants; Biguanides; Cerebral Cortex; Dose-Response Relationship, Drug; Hippocampus | 2016 |
Obtundation and seizure following ondansetron overdose in an infant.
Topics: Antiemetics; Humans; Infant; Male; Ondansetron; Poisoning; Seizures; Treatment Outcome; Unconsciousn | 2008 |
Ondansetron and seizures.
Topics: Adult; Electroencephalography; Epilepsy; Epilepsy, Tonic-Clonic; Female; Follow-Up Studies; Humans; | 2009 |
Ondansetron-induced dystonia, hypoglycemia, and seizures in a child.
Topics: Antiemetics; Child, Preschool; Dystonia; Humans; Hypoglycemia; Male; Ondansetron; Seizures; Serotoni | 2011 |
Evaluation of anticonvulsant and nootropic effect of ondansetron in mice.
Topics: Animals; Anticonvulsants; Behavior, Animal; Electroshock; Male; Mice; Nootropic Agents; Ondansetron; | 2012 |
Determinants of drug brain uptake in a rat model of seizure-associated malformations of cortical development.
Topics: Animals; Anticonvulsants; Astrocytes; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood | 2006 |
Seizure associated with ondansetron.
Topics: Adult; Gram-Negative Bacterial Infections; Humans; Male; Nausea; Ondansetron; Seizures; Shock, Septi | 1993 |
Generalised seizures following ondansetron.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Epi | 2001 |
Influence of phenytoin on the disposition of irinotecan: a case report.
Topics: Adolescent; Anticonvulsants; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy | 2002 |